
Paxlovid Tablet (Nirmatrelvir, Ritonavir)
150mg
Tablet · Prescription medication · Combination
Pfizer Korea Co., Ltd.
Nirmatrelvir is an antiviral agent that inhibits the replication of the COVID-19 virus.
MFDS ingredient code M281904
Nirmatrelvir is an antiviral agent used for the treatment of COVID-19, working by interfering with the replication of the virus. This agent targets specific enzymes of the COVID-19 virus to prevent the spread of infection.
Nirmatrelvir blocks the proteolytic enzymes necessary for the replication of the COVID-19 virus, preventing the virus from replicating in the body. This helps reduce the spread of infection and alleviate symptoms.
Approved uses differ by product. Check each product's information for its actual use.
Nirmatrelvir is a protease inhibitor specifically designed for the treatment of COVID-19, characterized by its targeting of the proteolytic enzymes of the COVID-19 virus directly, unlike other antiviral agents.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.